Begge tester påviser neutrofil-drevet intestinal betennelse, men kalprotektin er vanligvis det mer nyttige kvantitative overvåkingsverktøyet. Det riktige resultatet er et som endrer neste kliniske avgjørelse – ikke et som gir deg en IBD-diagnose.
- Kalprotektin under 50 µg/g er generelt betryggende hos voksne med mistanke om IBS når det ikke er noen alarmerende symptomer.
- Laktoseferrin er et neutrofilt protein; mange kvantitative analyser bruker mindre enn 7,25 µg/g som negativ, men laboratorie-grenseverdier varierer.
- Høy avføringsmarkører indikerer intestinal betennelse, ikke en spesifikk diagnose; infeksjon, NSAIDs, divertikulitt og kolorektal neoplasi kan øke begge.
- Grenseverdi for kalprotektin på 50–150 µg/g fortjener ofte en ny prøve etter 2–6 uker heller enn umiddelbar koloskopi.
- Kalprotektin over 250 µg/g øker bekymringen for aktiv slimhinnebetennelse og medfører vanligvis klinisk vurdering, testing for tarminfeksjon eller planlegging av endoskopi.
- Normale resultater kan gjøre aktiv kolitt-IBD mindre sannsynlig, men kan ikke pålitelig utelukke isolert tynntarms-Crohns sykdom.
- IBD-overvåking bruker symptomer pluss biomarkører, CRP, anæmi-markører, bildediagnostikk og endoskopi; ingen av avføringsmarkørene alene diagnostiserer et utbrudd.
- Akutte symptomer som svart avføring, vedvarende synlig blod, feber, sterke smerter, besvimelse eller dehydrering krever medisinsk vurdering uavhengig av en markørresultat.
Hvilken avføringsmarkør bør du velge først?
Fekal kalprotektin er vanligvis den førstevalgs-avføringsmarkøren for inflammasjon fordi den er allment tilgjengelig, kvantitativ og har den sterkeste rollen i å skille sannsynlig inflammatorisk tarmsykdom fra funksjonelle tarmsymptomer. Fekal laktoferrin-test resultater er et fornuftig alternativ når det er den lokalt validerte analysen, men å bestille begge i utgangspunktet endrer sjelden behandlingen.
For en person med 6 uker med løs avføring, kramper, og ingen vekttap eller rektal blødning, ville jeg generelt starte med kalprotektin pluss målrettet infeksjons testing fremfor koloskopi. Et resultat under 50 µg/g gjør betydelig tarminflammasjon mindre sannsynlig, mens et klart forhøyet resultat gir grunn til å undersøke nærmere. AGA-retningslinjen for kronisk vannaktig diaré støtter kalprotektin eller laktoseferrin som screeningtester for inflammatoriske tilstander (Smalley et al., 2019).
Velg laktoseferrin når din gastroenterologiavdeling bruker den konsekvent, når laboratoriet rapporterer en validert kvantitativ verdi, eller når den er inkludert i en arbeidsflyt for infeksiøs diaré. Ikke velg den fordi den høres mer spesifikk ut: begge proteiner frigjøres når nøytrofiler kommer inn i tarmlumen. Det praktiske problemet er om legen din kan sammenligne resultatet med dine tidligere prøver ved hjelp av samme analyse.
Kantesti er en AI-blodprøveanalysator som plasserer relaterte resultater som hemoglobin, CRP, albumin og jernindekser sammen med en rapport om avføringsmarkører; det erstatter ikke avføringsanalysen eller en leges diagnose. Hvis tretthet ledsager diaré, kan en blodprøve for diaré bidra til å identifisere dehydrering, anemi eller elektrolyttap som endrer alvorlighetsgraden.
En nyttig tommelfingerregel
Bruk én validert markør først, gjenta samme markør når et resultat er grensetilfelle eller ved overvåking av behandling, og reserver dobbelttesting for et spesifikt gastroenterologisk spørsmål. Å bytte analyse halvveis i oppfølgingen skaper tilsynelatende trender som kan være laboratoriestøy snarere enn biologi.
Hva avførings-kalprotektin faktisk påviser
Kalprotektin måler et kalsium- og sinkbindende protein som frigjøres hovedsakelig fra nøytrofiler i tarmen. En høyere avføringskonsentrasjon reflekterer nøytrofilmigrasjon inn i tarmen, noe som er vanlig ved aktiv IBD, men forekommer også ved flere tilstander utenom IBD.
Kalprotektin er S100A8/S100A9 proteinkomplekset, og det forblir relativt stabilt i avføring i flere dager ved romtemperatur – en grunn til at det fungerer godt som en hjemmeinnsamlingstest. Dens biologiske styrke er lokalt: i motsetning til CRP, reflekterer det cellulær aktivitet i tarmlumen snarere enn en systemisk akuttfase-respons. Et normalt CRP avbryter derfor ikke et høyt kalprotektinresultat.
I voksenpraksis klassifiserer laboratorier vanligvis mindre enn 50 µg/g som normalt og mer enn 150–250 µg/g som stadig mer forenlig med aktiv tarminflammasjon. Dette er beslutningsterskler, ikke universelle biologiske grenser. Noen europeiske tjenester bruker 100 µg/g som henvisningsterskel, mens intervaller for pediatriske og analyse-spesifikke referanser kan avvike betydelig.
Jeg har sett en 28-åring med et kalprotektin på 680 µg/g, et normalt CRP, og til slutt ulcerøs kolitt begrenset til rektum og sigmoideum. Dette mønsteret er ikke uvanlig: lokal slimhinnebetennelse kan være aktiv uten et sterkt systemisk signal. Vårt fecal calprotectin range guide explains why the laboratory’s own method and units should stay attached to every result.
Hva avførings-laktoseferrin påviser annerledes
Lactoferrin detects another neutrophil-derived protein and answers nearly the same biological question as calprotectin: is there active intestinal neutrophil inflammation? It does not identify ulcerative colitis, Crohn’s disease, bacterial colitis, or another cause on its own.
Lactoferrin is an iron-binding glycoprotein stored in neutrophil secondary granules and released during activation. A positive qualitative fecal lactoferrin test is useful because it argues against uncomplicated IBS in the right clinical setting. Quantitative assays vary: one commonly used method defines a negative value as less than 7.25 µg/g, so never apply a calprotectin cutoff to a lactoferrin report.
The evidence does not show that lactoferrin is categorically superior. In a diagnostic meta-analysis, Wang and colleagues found fecal lactoferrin had pooled sensitivity of 82% and specificity of 95% for distinguishing IBD from non-IBD controls, although accuracy estimates shift with disease prevalence and study design (Wang et al., 2015). That impressive specificity still does not convert a positive result into an IBD diagnosis.
A positive lactoferrin result is especially worth discussing when diarrhoea began abruptly after travel, antibiotics, contaminated food exposure, or contact with someone unwell. In those situations, clinicians usually add pathogen testing rather than jumping straight to an IBD label. Our guide to resultater fra avføringsdyrkning covers what a negative or mixed-growth report can and cannot settle.
Slik leser du grenseverdier uten å overreagere
A calprotectin value below 50 µg/g is usually normal for adults, 50–150 µg/g is often an indeterminate zone, and values above 250 µg/g raise concern for active inflammation. Lactoferrin uses assay-specific cutoffs, commonly a qualitative positive or a quantitative threshold near 7.25 µg/g.
The 50 µg/g calprotectin threshold is designed for sensitivity: it catches most clinically significant inflammatory disease at the cost of some false positives. The 250 µg/g threshold is more useful for specificity and for monitoring established IBD. Between them lies the frustrating middle, where medication exposure, recent gastroenteritis, age, and trajectory matter more than a single number.
A change from 72 to 94 µg/g is often less meaningful than a change from 85 to 430 µg/g, particularly if both samples were tested by the same laboratory. Stool consistency can influence extraction and biological variation is real. Dr. Thomas Klein’s practical advice is to record NSAID use, recent infection, menstrual contamination, and collection date before interpreting a modest rise.
For a disciplined approach to serial values, compare the sample date with symptoms and related labs rather than treating every flagged result as disease progression. Our veiledning for blodprøvetrender explains the same principle of reference change and analytic variation in laboratory medicine.
Hvorfor begge markører kan være forhøyet uten IBD
Elevated stool inflammation markers occur with enteric infection, NSAID exposure, diverticulitis, colorectal neoplasia, microscopic colitis and IBD. The result confirms an inflammatory signal; it does not disclose the cause, location, duration, or severity by itself.
Non-steroidal anti-inflammatory drugs can raise fecal calprotectin, sometimes substantially, by increasing intestinal permeability and causing small mucosal injuries. Ibuprofen, naproxen and diclofenac matter; a clinician may suggest withholding them if medically safe before repeating the test. Do not stop prescribed aspirin, anticoagulants, or pain medicines without asking the prescriber first.
Acute bacterial gastroenteritis may produce calprotectin values above 500 µg/g and a positive lactoferrin, which is why a stool pathogen panel can be more informative than an urgent colonoscopy in the first days of illness. Conversely, giardiasis may cause prolonged diarrhoea with less striking neutrophilic marker elevation. The symptom timeline often carries more diagnostic weight than patients expect.
Kantesti er en AI lab test interpretation service that can flag an inflammation pattern such as low hemoglobin, low albumin, thrombocytosis and raised CRP for clinician review, but those blood findings do not prove the source is intestinal. For people with blood in the stool, FIT follow-up and colonoscopy timing is a separate issue from calprotectin and should not be delayed.
Når et normalt resultat likevel kan overse sykdom
Normal calprotectin or lactoferrin makes active colonic inflammation less likely, but it cannot fully exclude Crohn’s disease, particularly mild or isolated small-bowel disease. A normal result also does not explain persistent weight loss, iron-deficiency anemia, nocturnal diarrhoea, or recurrent visible bleeding.
Small-bowel Crohn’s disease can shed less neutrophil protein into a stool sample than extensive colitis, especially when lesions are proximal or mild. This is one reason symptoms and alarm features overrule a reassuring number. The ECCO-ESGAR diagnostic guideline recommends integrating biomarkers with ileocolonoscopy and cross-sectional imaging when IBD remains clinically suspected (Maaser et al., 2019).
A 46-year-old with calprotectin of 38 µg/g, ferritin of 7 ng/mL, and progressive fatigue deserves evaluation for gastrointestinal blood loss or malabsorption even if bowel frequency is normal. In my experience, the combination of iron deficiency and unexplained symptoms is much more consequential than a single low stool marker. Read our low ferritin and gut clues for the usual next laboratory questions.
Celiac disease, bile acid diarrhoea, pancreatic insufficiency and many medication effects may cause symptoms with normal stool inflammation markers. A normal test is therefore a fork in the road toward non-inflammatory diagnoses, not a declaration that symptoms are psychological or unimportant.
Hva du skal gjøre med et grensetilfelle av kalprotektin-resultat
A borderline fecal calprotectin result of 50–150 µg/g is commonly repeated after 2–6 weeks if symptoms are stable and there are no alarm features. The repeat should use the same laboratory method and should be timed away from a recent gastrointestinal infection where possible.
Before retesting, clinicians review NSAIDs, proton-pump inhibitors, antibiotics, acute infections, strenuous endurance exercise and age-related risk. There is no universally agreed washout interval for every medicine. A pragmatic plan is often 2 weeks after an acute illness has settled, provided symptoms do not signal a need for earlier care.
If the repeat falls from 118 to 32 µg/g and symptoms settle, invasive testing may be avoidable. If it rises from 96 to 310 µg/g, the direction adds useful evidence even before an endoscopy result arrives. This is why a single borderline value should rarely trigger panic—or false reassurance.
Vår borderline calprotectin follow-up guide lays out the questions to bring to a primary-care or gastroenterology appointment. A short symptom diary with stool frequency, nighttime waking, fever and medication dates is usually more useful than obsessively checking food triggers.
Hvordan klinikere bruker markører etter at IBD er diagnostisert
In established IBD, calprotectin is most useful for tracking objective intestinal inflammation and helping decide whether symptoms represent a flare, infection, IBS overlap, or treatment failure. Lactoferrin can also follow activity, but calprotectin has more guideline-supported thresholds for treat-to-target monitoring.
Symptoms and mucosal activity frequently diverge. A patient with ulcerative colitis may feel well while calprotectin climbs from 80 to 360 µg/g, or have urgent bowel motions from bile acid malabsorption while calprotectin remains 28 µg/g. The 2023 AGA ulcerative colitis biomarker guideline advises combining symptoms with biomarkers rather than relying on either alone (Singh et al., 2023).
For remission monitoring, many clinicians view less than 150 µg/g as reassuring, while more than 150 µg/g may warrant repeat testing, endoscopy, or treatment review depending on symptoms and prior disease behaviour. In active symptomatic ulcerative colitis, more than 250 µg/g supports ongoing inflammation. Cutoffs are guides, not instructions to alter biologic treatment without specialist input.
Kantesti AI er en AI-plattform for tolkning av biomarkører that organizes blood-test trends around a patient’s reported treatment dates; it cannot assess stool endoscopic severity from a number alone. Patients taking biologics should also understand which blood safety tests monitor treatment and which symptoms require prompt contact with their IBD team.
Hvordan innsamlingsfeil og tidspunkt påvirker resultater
Collection quality affects stool marker interpretation because a contaminated, delayed, or poorly sampled specimen can be rejected or produce a less reliable measurement. Most laboratories want a small stool portion placed into the supplied sterile container without toilet water or urine.
Loose stool is usually acceptable for calprotectin and lactoferrin testing; do not wait for a formed sample if diarrhoea is the clinical problem. Avoid collecting from toilet water, and tell the laboratory if the sample includes visible menstrual blood. Storage instructions vary by kit, but many allow short room-temperature transport because calprotectin is comparatively stable.
Sampling a day after a marathon, a bout of gastroenteritis, or colonoscopy bowel preparation may answer the wrong question. Endurance exercise can transiently increase gut permeability and provoke gastrointestinal symptoms. If you are an endurance athlete without red flags, consider timing collection away from a major event; our endurance athlete lab guide explains why context changes test interpretation.
The thing is, a perfect collection does not make a nonspecific biomarker specific. A high-quality sample improves confidence in the measurement; it cannot replace the clinical history, examination, and differential diagnosis.
Hvilke blodprøver som gjør en avføringsmarkør mer nyttig
A CBC, CRP, ferritin, albumin, kidney function and celiac serology often add more clinical value to a raised stool marker than ordering a second stool inflammation protein. The concerning pattern is not any one abnormality but several results that point toward inflammation, malabsorption, or blood loss.
Low hemoglobin, ferritin below 15 ng/mL, albumin below the laboratory reference range, raised platelets, or raised CRP can strengthen concern for clinically meaningful bowel disease. None is diagnostic of IBD. In fact, CRP may remain normal in mild ulcerative colitis, and ferritin can look falsely normal when inflammation raises it as an acute-phase protein.
Kantesti er en AI-powered blood test analysis tool that reads a CBC, iron studies and CRP in the same clinical frame, including whether a changing hemoglobin level might justify earlier review. Dr. Thomas Klein routinely cautions that an isolated CRP of 12 mg/L is nonspecific, whereas CRP 12 mg/L plus falling albumin and a calprotectin of 740 µg/g is a much more actionable cluster.
For patients whose iron values seem contradictory, our iron studies research guide explains transferrin saturation and ferritin during inflammation. A CBC result guide can also help you identify whether anemia is microcytic, inflammatory, or mixed.
Når det kan være fornuftig å bestille begge tester
Ordering calprotectin and lactoferrin together is usually unnecessary, but it can be reasonable when a specialist is reconciling discordant symptoms, a prior assay cannot be repeated, or a local pathway requires confirmation. Concordant results modestly increase confidence in an inflammatory signal; discordant results usually trigger review, not arithmetic averaging.
A high calprotectin with negative lactoferrin may reflect assay timing, a result near the cutoff, specimen heterogeneity, or analytical differences. A low calprotectin with positive lactoferrin deserves the same disciplined response: verify collection, review the exact assay, check symptoms and test for infection when appropriate. Neither combination has a validated shortcut to diagnosis.
Dual testing can also be useful in research settings where a protocol prespecifies both biomarkers. That is different from routine patient care, where duplicate testing can add cost without improving decisions. Ask the ordering clinician a simple question: “What will we do differently if the second test is positive?”
If a report looks internally inconsistent, use our kvalitativ kontra kvantitativ testguide to understand why “positive” and “high” are not interchangeable laboratory statements. Consistency of method matters more than collecting every available marker.
Hva som faktisk bekrefter eller utelukker IBD
IBD is diagnosed through a synthesis of symptoms, ileocolonoscopy with tissue sampling, histology, laboratory tests, and sometimes MRI or CT enterography—not from calprotectin or lactoferrin alone. Stool markers help decide who needs these investigations and whether inflammation may be changing over time.
Colonoscopy allows direct assessment of the terminal ileum and colon and permits tissue examination for chronic inflammatory features, infection, microscopic colitis, dysplasia, and other causes. Imaging is particularly valuable when Crohn’s disease may involve small bowel beyond the reach of a standard colonoscopy. A stool marker is a triage signal, not a microscopic diagnosis.
Do not confuse a fecal immunochemical test with either inflammatory marker. FIT detects human hemoglobin and is used primarily in colorectal cancer screening or lower-GI bleeding pathways, whereas calprotectin and lactoferrin detect neutrophil products. Our comparison of FIT and FOBT explains why a negative inflammation marker does not substitute for recommended cancer screening.
As of September 4, 2026, no major gastroenterology guideline recommends diagnosing Crohn’s disease or ulcerative colitis from a single stool biomarker threshold. That restraint protects patients from both missed disease and unnecessary lifelong diagnostic labels.
Symptomer som overskygger ethvert avføringsprøveresultat
Persistent visible rectal bleeding, black tarry stool, severe abdominal pain, fever, fainting, dehydration, rapidly worsening weakness, or unintended weight loss need timely medical assessment regardless of calprotectin or lactoferrin. A normal result should never be used to wait out a potentially urgent symptom pattern.
The urgent concern is physiology, not the label on a laboratory report. Frequent watery diarrhoea can produce low potassium, acute kidney injury, and orthostatic symptoms before an inflammation marker returns. Adults with inability to keep fluids down, confusion, fainting, or minimal urine output should seek urgent care.
New bowel symptoms after age 50, a strong family history of colorectal cancer, and iron-deficiency anemia alter the threshold for colon evaluation even when calprotectin is low. A stool marker does not assess cancer risk comprehensively. Our mucus in stool red-flag guide distinguishes common benign patterns from symptoms that need examination.
Children, pregnant people, older adults, and people using immune-suppressing medicines need individualized triage because their baseline risks differ. If you are unsure whether symptoms are urgent, contacting a local clinician or urgent-care service is safer than trying to interpret a number in isolation.
En praktisk samtale å ha etter resultatet ditt
The most useful follow-up question is: “Does this result change my need for infection testing, repeat testing, imaging, or endoscopy?” Bringing the exact value, assay name, symptom timeline, medicines, and previous results makes that conversation faster and more clinically precise.
Bring a list of the previous 14 days: stool frequency, overnight symptoms, fever, weight change, travel, antibiotics, NSAIDs, and family history. A calprotectin of 180 µg/g after a 3-day febrile diarrhoeal illness calls for a different plan than the same result after 4 months of nocturnal diarrhoea and weight loss.
Kantesti AI can help you organize accompanying blood reports before an appointment, but diagnosis and treatment decisions belong with the clinician who can examine you and arrange definitive testing. Our medisinske valideringsmetode explains how clinical oversight and source checking are built into responsible laboratory interpretation.
For complex cases, ask who will own the follow-up and when you should expect a repeat result or referral decision. The clinicians on our Medisinsk rådgivende styre emphasize that a documented plan beats a vague instruction to “recheck later,” especially when inflammation markers and anemia move in the same direction.
Den avgjørelsesfokuserte konklusjonen
Choose calprotectin first in most settings, use lactoferrin when it is your service’s validated alternative, and do not assume either result diagnoses IBD. A low result shifts attention toward functional and non-inflammatory causes, while a persistently high result identifies people who may need infection testing, specialist review, or endoscopy.
For uncomplicated chronic diarrhoea, one normal marker—calprotectin below 50 µg/g or a negative lactoferrin according to that laboratory—can reduce the likelihood of active inflammatory disease. For a value above 250 µg/g or a positive lactoferrin with persistent symptoms, the next question is cause, not certainty. Infection, medicine exposure, IBD, and other inflammatory conditions remain on the list.
Most patients find the ambiguity hardest in the 50–150 µg/g calprotectin zone. In my experience, the best next step is usually a carefully timed repeat, not a dietary cleanse, self-directed steroid use, or an internet diagnosis. Keep the same laboratory where feasible so the trend is interpretable.
Kantesti’s veiledning for AI-teknologi describes how our systems preserve laboratory context while highlighting questions for medical review. The safe use of any AI interpretation is the same here: use it to prepare for a better clinical conversation, never to override red flags or replace diagnostic care.
Frequently Asked Questions
Er kalprotektin bedre enn laktoseferrin for påvisning av inflammatorisk tarmsykdom?
Kalprotektin foretrekkes vanligvis ved mistanke om IBD fordi den er allment tilgjengelig som en kvantitativ test og har ofte brukte terskelverdier for overvåking, som mindre enn 50 µg/g og mer enn 250 µg/g. Laktoseferrin er også en nyttig avføringsmarkør avledet fra nøytrofiler, og kan prestere godt når laboratoriet bruker en validert analysemetode. Ingen av markørene bekrefter IBD, fordi infeksjoner, NSAIDs, divertikulitt og andre tarmsykdommer kan øke begge. Den bedre testen er vanligvis den legen din kan tolke sammen med symptomer og gjenta ved bruk av samme laboratoriemetode.
Hvilket nivå av kalprotektin er bekymringsfullt?
Et fekalt kalprotektinnivå under 50 µg/g er generelt betryggende for voksne uten faresymptomer, mens 50–150 µg/g ofte anses som grenseverdi og kan gjentas etter 2–6 uker. Verdier over 150–250 µg/g er mer bekymringsfullt for tarmbetennelse, og nivåer over 250 µg/g utløser vanligvis klinisk vurdering eller ytterligere testing. Nøyaktig handling avhenger av analysen, symptomer, alder, bruk av NSAIDs og om verdien stiger. En verdi på 600 µg/g etter akutt bakteriell diaré kan ha en annen betydning enn 600 µg/g under flere måneders kroniske symptomer.
Kan IBS forårsake høy calprotectin eller laktoferrin?
Ukomplisert IBS gir vanligvis ikke forhøyet fekal kalprotektin eller laktoseferrin fordi IBS ikke forårsaker nøytrofil-drevet tarmbetennelse. Milde kalprotektinøkninger mellom 50 og 150 µg/g kan oppstå som følge av nylig infeksjon, bruk av NSAIDs, aldersrelaterte faktorer eller variasjoner i analysen, så de utelukker ikke automatisk IBS. Et positivt laktoseferrin eller kalprotektin over 250 µg/g bør utløse en vurdering for en inflammatorisk eller infeksiøs årsak i stedet for å anta IBS. IBS og IBD kan sameksistere, noe som er en annen grunn til at symptomer og trender er viktige.
Can a normal calprotectin rule out Crohn's disease?
Et normalt calprotectinresultat reduserer sannsynligheten for aktiv IBD i tykktarmen, men kan ikke fullstendig utelukke Crohns sykdom, spesielt mild eller isolert Crohns sykdom i tynntarmen. En verdi under 50 µg/g bør ikke overstyre alarmsymptomer som jernmangelanemi, vekttap, nattlig diaré, vedvarende blødning eller en sterk familiehistorie. Klinikere kan bruke ileokoloskopi, MR enterografi eller kapselundersøkelse når klinisk mistanke vedvarer. Resultatet bør best behandles som et sannsynlighetsjusterende bevis snarere enn en endelig utelukkelsestest.
Bør jeg gjenta et grensetilfelle av kalprotektinresultat?
Et grensetilfelle av kalprotektinresultat på 50–150 µg/g gjentas ofte etter 2–6 uker når symptomene er stabile og det ikke er noen alarmsymptomer. Før gjentakelse vurderer klinikere vanligvis nylig gastroenteritt, NSAID-bruk, antibiotika og innsamlingsforhold, fordi hver av disse kan påvirke verdien. Bruk samme laboratorieanalyse om mulig, da resultater fra ulike metoder kanskje ikke er direkte sammenlignbare. Et stigende resultat mot eller over 250 µg/g har generelt mer klinisk vekt enn en stabil lavgradig forhøyelse.
Kan antibiotika påvirke fekal kalprotektin og laktoseferrin?
Antibiotika kan indirekte påvirke inflammatoriske markører i avføringen ved å behandle, utløse eller falle sammen med infeksiøs diaré, og ved å endre tarmmikrobiomet. En person med antibiotika-assosiert diaré bør utredes for årsaker som Clostridioides difficile, i stedet for å tolke forhøyet calprotectin eller positivt laktoseferrin som IBD. Det finnes ikke noe pålitelig universelt antall dager å vente etter antibiotikabehandling før testing; tidspunktet avhenger av symptomer og det kliniske spørsmålet. Vedvarende diaré, feber eller magesmerter etter antibiotikabehandling krever legeledet utredning fremfor egenbehandling.
Get AI-Powered Blood Test Analysis Today
Join over 2 million users worldwide who trust Kantesti for instant, accurate lab test analysis. Upload your blood test results and receive comprehensive interpretation of 15,000+ biomarkers in seconds.
📚 Referenced Research Publications
Klein, T., Mitchell, S., & Weber, H. (2026). Kantesti LTD. (2026). Urobilinogen i urinprøve: Komplett urinanalyseguide 2026. Zenodo.. Kantesti AI Medical Research.
Klein, T., Mitchell, S., & Weber, H. (2026). Kantesti LTD. (2026). Iron Studies Guide: TIBC, Iron Saturation & Binding Capacity. Zenodo.. Kantesti AI Medical Research.
📖 External Medical References
Singh S et al. (2023). AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis. Gastroenterologi.
⚕️ Medical Disclaimer
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment decisions.
E-E-A-T Trust Signals
Experience
Physician-led clinical review of lab interpretation workflows.
Expertise
Laboratory medicine focus on how biomarkers behave in clinical context.
Authoritativeness
Written by Dr. Thomas Klein with review by Dr. Sarah Mitchell and Prof. Dr. Hans Weber.
Trustworthiness
Evidence-based interpretation with clear follow-up pathways to reduce alarm.